ATE181918T1 - Purinderivate und ihre pharmazeutisch akzeptablen salze - Google Patents

Purinderivate und ihre pharmazeutisch akzeptablen salze

Info

Publication number
ATE181918T1
ATE181918T1 AT95104408T AT95104408T ATE181918T1 AT E181918 T1 ATE181918 T1 AT E181918T1 AT 95104408 T AT95104408 T AT 95104408T AT 95104408 T AT95104408 T AT 95104408T AT E181918 T1 ATE181918 T1 AT E181918T1
Authority
AT
Austria
Prior art keywords
present
purine derivatives
compounds
pharmaceutically acceptable
acceptable salts
Prior art date
Application number
AT95104408T
Other languages
English (en)
Inventor
Kaoru Okamoto
Taisuke Hasegawa
Akio Namimatsu
Original Assignee
Nippon Zoki Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zoki Pharmaceutical Co filed Critical Nippon Zoki Pharmaceutical Co
Application granted granted Critical
Publication of ATE181918T1 publication Critical patent/ATE181918T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28—Oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT95104408T 1994-03-25 1995-03-24 Purinderivate und ihre pharmazeutisch akzeptablen salze ATE181918T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP07933694A JP3497554B2 (ja) 1994-03-25 1994-03-25 新規プリン誘導体及びその薬学的に許容される塩

Publications (1)

Publication Number Publication Date
ATE181918T1 true ATE181918T1 (de) 1999-07-15

Family

ID=13687063

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95104408T ATE181918T1 (de) 1994-03-25 1995-03-24 Purinderivate und ihre pharmazeutisch akzeptablen salze

Country Status (10)

Country Link
US (1) US5658918A (de)
EP (1) EP0673938B1 (de)
JP (1) JP3497554B2 (de)
KR (1) KR100355096B1 (de)
CN (1) CN1045443C (de)
AT (1) ATE181918T1 (de)
AU (1) AU683981B2 (de)
CA (1) CA2145432A1 (de)
DE (1) DE69510582T2 (de)
TW (1) TW416957B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9721189D0 (en) 1997-10-08 1997-12-03 Speywood Lab The Limited Analgesic conjugates
US20040071736A1 (en) 1998-08-25 2004-04-15 Health Protection Agency Methods and compounds for the treatment of mucus hypersecretion
US8790897B2 (en) 1998-08-25 2014-07-29 Syntaxin Ltd. Treatment of mucus hypersecretion
GB9818548D0 (en) * 1998-08-25 1998-10-21 Microbiological Res Authority Treatment of mucas hypersecretion
US20090023723A1 (en) * 2005-09-21 2009-01-22 Pharmacopeia Drug Discovery, Inc. Purinone derivatives for treating neurodegenerative diseases
NZ579248A (en) * 2007-03-28 2011-08-26 Neurosearch As Purinyl derivatives and their use as potassium channel modulators
JP2014076947A (ja) * 2011-02-03 2014-05-01 Dainippon Sumitomo Pharma Co Ltd ２−オキシ置換８−オキソジヒドロプリン誘導体
CN108069969B (zh) * 2016-11-11 2020-09-18 南京海璞医药科技有限公司 含氮杂环化合物、制备方法、中间体、药物组合物和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52120135A (en) * 1976-03-30 1977-10-08 Nippon Zoki Pharmaceutical Co Alllnerve tranquilling agent
JPS6058726B2 (ja) * 1977-10-05 1985-12-21 日本臓器製薬株式会社 プリン誘導体を有効成分として含有する抗アレルギ−，鎮痛，鎮静剤
JPH01299229A (ja) * 1988-05-25 1989-12-04 Rohto Pharmaceut Co Ltd 肥満症治療剤
FR2659656B1 (fr) * 1990-03-15 1994-09-09 Sanofi Sa Derives de pyrimidinedione-2,4 et medicaments les contenant.

Also Published As

Publication number Publication date
AU683981B2 (en) 1997-11-27
KR950032194A (ko) 1995-12-20
AU1508995A (en) 1995-10-05
DE69510582T2 (de) 1999-11-25
EP0673938B1 (de) 1999-07-07
DE69510582D1 (de) 1999-08-12
CA2145432A1 (en) 1995-09-26
CN1045443C (zh) 1999-10-06
US5658918A (en) 1997-08-19
CN1114318A (zh) 1996-01-03
EP0673938A2 (de) 1995-09-27
JP3497554B2 (ja) 2004-02-16
KR100355096B1 (ko) 2002-12-26
TW416957B (en) 2001-01-01
EP0673938A3 (de) 1995-11-08
JPH07258257A (ja) 1995-10-09

Similar Documents

Publication Publication Date Title
NO890723D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 3-alkenyl-1-azabicyklo(3.2.0)hept2-en-2-karboksylsyrederivater.
NO159017C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,2,3,4-tetrahydroisokinolin-3-karboksylsyre-derivater.
ATE223378T1 (de) Prolineamid-derivate
ATE230729T1 (de) Benzamid-derivate und ihre verwendung als vasopressin-antagonisten
ATE109149T1 (de) 3-pyrrolidinylthio-1-azabicyclo(3.2.0>-hept-2-e - 2-carbonsäureverbindungen.
ATE107306T1 (de) 3-pyrrolidinylthio-1-azabicyclo (3.2.0)hept-2-en- 2-carbonsäure-verbindungen.
ATE181918T1 (de) Purinderivate und ihre pharmazeutisch akzeptablen salze
ATE156119T1 (de) 2-formylpyridin-thiosemicarbazonderivate, ihre herstellung und ihre verwendung als antitumor mittel
NO20020804L (no) Nye A-500359-derivater
AU7453501A (en) Hydroxyformamidine derivatives and medicines containing the same
MX9206930A (es) Nuevos compuestos
ATE172959T1 (de) Acylphenylglycin-derivat und dieses als aktivbestandteil enthaltendes vorbeugungs -und heilmittel gegen durch erhöhte collagenaseaktivität verursachte krankheiten
NO894325L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrrolidin-derivater.
DE69118784D1 (de) Neue Peptidderivate und deren pharmazeutischer Gebrauch
IL110369A0 (en) Pharmaceutical compositions for the prevention and/or treatment of gastrointestinal diseases including ulcer

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties